X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13422) 13422
Publication (878) 878
Book Chapter (185) 185
Book Review (182) 182
Conference Proceeding (18) 18
Magazine Article (11) 11
Dissertation (4) 4
Book / eBook (3) 3
Web Resource (3) 3
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anticoagulation (9434) 9434
humans (9040) 9040
index medicus (6282) 6282
female (5187) 5187
male (5144) 5144
aged (4091) 4091
warfarin (3982) 3982
middle aged (3697) 3697
anticoagulants - therapeutic use (3609) 3609
atrial fibrillation (3190) 3190
anticoagulants (2989) 2989
cardiac & cardiovascular systems (2910) 2910
stroke (2528) 2528
risk factors (2499) 2499
therapy (2334) 2334
anticoagulants - administration & dosage (2202) 2202
anticoagulants - adverse effects (2199) 2199
adult (2004) 2004
treatment outcome (1994) 1994
management (1945) 1945
peripheral vascular disease (1926) 1926
hematology (1902) 1902
aged, 80 and over (1878) 1878
oral anticoagulation (1856) 1856
risk (1650) 1650
thromboembolism (1609) 1609
thrombosis (1604) 1604
retrospective studies (1591) 1591
prevention (1475) 1475
atrial fibrillation - drug therapy (1430) 1430
warfarin - therapeutic use (1364) 1364
surgery (1269) 1269
international normalized ratio (1264) 1264
medicine, general & internal (1261) 1261
atrial fibrillation - complications (1246) 1246
stroke - prevention & control (1221) 1221
heparin (1114) 1114
care and treatment (1098) 1098
aspirin (1094) 1094
atrial-fibrillation (1084) 1084
hemorrhage - chemically induced (1082) 1082
pharmacology & pharmacy (1051) 1051
venous thromboembolism (1039) 1039
antithrombotic therapy (1011) 1011
medicine & public health (991) 991
warfarin - adverse effects (982) 982
prospective studies (968) 968
warfarin - administration & dosage (955) 955
mortality (950) 950
administration, oral (939) 939
time factors (933) 933
abridged index medicus (867) 867
risk-factors (866) 866
analysis (847) 847
stroke - etiology (844) 844
stroke prevention (842) 842
bleeding (830) 830
cardiology (830) 830
risk assessment (823) 823
molecular-weight heparin (805) 805
complications (798) 798
drug therapy (798) 798
hemorrhage (792) 792
follow-up studies (782) 782
clinical neurology (763) 763
dabigatran (756) 756
patients (718) 718
thromboembolism - prevention & control (703) 703
health aspects (685) 685
anticoagulation therapy (661) 661
guidelines (620) 620
incidence (614) 614
prevalence (602) 602
research (594) 594
cardiac arrhythmia (581) 581
blood coagulation - drug effects (574) 574
fibrinolytic agents - therapeutic use (574) 574
platelet aggregation inhibitors - therapeutic use (573) 573
outcomes (567) 567
adolescent (566) 566
safety (565) 565
cardiovascular (556) 556
dosage and administration (548) 548
trial (543) 543
internal medicine (535) 535
antiplatelet therapy (531) 531
metaanalysis (530) 530
cohort studies (526) 526
rivaroxaban (519) 519
atrial fibrillation - therapy (513) 513
urology & nephrology (504) 504
pulmonary embolism (488) 488
diagnosis (479) 479
dose-response relationship, drug (469) 469
prognosis (467) 467
heparin - therapeutic use (466) 466
complications and side effects (464) 464
atrial fibrillation - epidemiology (462) 462
heparin - adverse effects (462) 462
recurrence (454) 454
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12322) 12322
German (554) 554
French (280) 280
Spanish (208) 208
Japanese (68) 68
Russian (52) 52
Portuguese (36) 36
Polish (25) 25
Korean (22) 22
Czech (18) 18
Italian (9) 9
Turkish (8) 8
Hungarian (7) 7
Slovak (4) 4
Chinese (3) 3
Dutch (2) 2
Icelandic (2) 2
Georgian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 6, pp. 1247 - 1257
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2008, Volume 51, Issue 8, pp. 818 - 825
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 05/2016, Volume 115, Issue 5, pp. 939 - 949
The effectiveness and safety of rivaroxaban for stroke prevention in atrial fibrillation (SPAF) demonstrated in ROCKET AF needs to be confirmed in daily care.... 
Persistence | Rivaroxaban | Anticoagulation | Atrial fibrillation | Bleeding | bleeding | MANAGEMENT | HEMORRHAGE | RISK | rivaroxaban | DISCONTINUATION | STROKE | RATES | atrial fibrillation | DABIGATRAN | WARFARIN | ORAL ANTICOAGULANTS | persistence | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | 2011 ACCF/AHA/SCAI GUIDELINE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | TRIPLE THERAPY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 09/2012, Volume 126, Issue 10, pp. 1185 - 1193
Background-Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or... 
atrial fibrillation | percutaneous coronary intervention | triple therapy | myocardial infarction | anticoagulants | antithrombotic treatment | hemorrhage | CARDIAC & CARDIOVASCULAR SYSTEMS | ORAL ANTICOAGULATION | HEART RHYTHM ASSOCIATION | RISK | EUROPEAN-SOCIETY | ASPIRIN | CONSENSUS DOCUMENT | STENT IMPLANTATION | DUAL ANTIPLATELET THERAPY | WARFARIN | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | CARDIOLOGY WORKING GROUP | Myocardial Infarction - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Hemorrhage - mortality | Male | Hemorrhage - prevention & control | Angioplasty, Balloon, Coronary | Aspirin - administration & dosage | Fibrinolytic Agents - adverse effects | Myocardial Infarction - therapy | Drug Therapy, Combination - adverse effects | Vitamin K - antagonists & inhibitors | Aspirin - adverse effects | Atrial Fibrillation - mortality | Registries - statistics & numerical data | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Stroke - mortality | Platelet Aggregation Inhibitors - adverse effects | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Denmark - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Cohort Studies | Usage | Thrombolytic drugs | Research | Hemorrhage | Risk factors
Journal Article
Stroke, ISSN 0039-2499, 11/2013, Volume 44, Issue 11, pp. 3103 - 3108
Journal Article
Circulation, ISSN 0009-7322, 02/2007, Volume 115, Issue 6, pp. 813 - 818
Journal Article
Journal Article